Natural Killer T cells

1. Introduction: Mechanisms of NKT-Cell-Mediated Adjuvant Activity and Function of iPS-Derived NKT Cells
Masaru Taniguchi, Shin-ichiro Fujii, Toshinori Nakayama, Shinichiro Motohashi, Nyambayar Dashtsoodol, Hiroshi Watarai, Michishige Harada

2. Structure and Recognition of Antigens for Invariant NKT Cells
Bo Pei, Mitchell Kronenberg

3. Invariant NKT Cell-Based Vaccine Strategies
John-Paul Jukes, Jonathan D. Silk, Mariolina Salio, Vincenzo Cerundolo

4. Immune Regulation of Tumor Immunity by NKT Cells
Jessica J. O’Konek, Jay A. Berzofsky, Masaki Terabe

5. The Regulation of CD1d+ and CD1d− Tumors by NKT Cells
Jianyun Liu, Gourapura J. Renukaradhya, Randy R. Brutkiewicz

6. DC-Based Immunotherapy Targeting NKT Cells
Shin-ichiro Fujii, Kanako Shimizu

7. Therapeutic Approaches Utilising NKT Cells
Stephen R. Mattarollo, Mark J. Smyth

8. NKT Cells of Cancer Patients and How Models Can Inform Therapeutic Plans
Mark A. Exley, Lydia Lynch, Michael Nowak

9. Understanding the Role of Natural Killer T Cells in Hematologic Malignancies: Progress and Challenges
Natalia Neparidze, Madhav V. Dhodapkar

10. Clinical Trials with α-Galactosylceramide (KRN7000) in Advanced Cancer
Famke L. Schneiders, Rik J. Scheper, Hetty J. Bontkes, B. Mary E. Blomberg, Alfons J. M. Eertwegh, Tanja D. Gruijl, Hans J. Vliet

11. Clinical Trials of Invariant Natural Killer T Cell-Based Immunotherapy for Cancer
Shinichiro Motohashi, Yoshitaka Okamoto, Toshinori Nakayama

Nyckelord: Biomedicine, Cancer Research, Pharmacology/Toxicology